Roche Roche Diagnostic Revenues Grow 38 Percent in First Nine Months of 2021 on Strong POC Test Sales The firm continued to see strong growth in COVID-19 testing sales and recovery in its base business. STIs Reached Record Highs, Then COVID-19 Hit. Test Makers Now Ponder What's Next Premium As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests. Labcorp Receives FDA EUA for Combo COVID-19/Flu Home Collection Kit The collection kit uses the Roche Cobas SARS-CoV-2 & Influenza A/B Test for use on the Cobas 6800/8800 Systems for testing nasal or nasopharyngeal samples. Roche Nabs CE Mark for Three Cobas Respiratory Test Panels The molecular panels, which can be run together or alone, detect and differentiate between common respiratory pathogens. Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio TIB Molbiol already has more than 45 CE-marked tests available on Roche's LightCycle PCR instruments and its MagNA Pure sample prep systems. Jul 22, 2021 Roche Reports Diagnostics Revenue Up 51 Percent in H1 Jul 13, 2021 Hyrax Biosciences, Roche Diagnostics Form SARS-CoV-2 Sequencing Tech Alliance Jul 6, 2021 Roche, Mimetas Partner to Develop Disease Models for Drug Discovery Jul 1, 2021 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor Jun 18, 2021 Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Jun 18, 2021 Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data Premium May 28, 2021 Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia May 26, 2021 Illumina, Roche Agree to Settle NIPT Patent Lawsuits Apr 21, 2021 Roche Diagnostics Q1 Sales Climb 50 Percent Apr 13, 2021 FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines Premium Apr 6, 2021 Roche to Use Oncimmune Infectious Disease Panel in COVID-19 Drug Trial Mar 19, 2021 New Products Posted to GenomeWeb: Roche, Twist Bioscience, Codex DNA, More Mar 16, 2021 Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Mar 15, 2021 Roche to Acquire GenMark Diagnostics for $1.8B Mar 12, 2021 FDA Warns of Potential False Positive Results With Roche Cobas Liat Rapid SARS-CoV-2, Flu Test Mar 11, 2021 Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification Mar 8, 2021 Bio-Rad Laboratories, Roche Enter Quality Control Partnership Feb 18, 2021 WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance Feb 11, 2021 Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples Feb 4, 2021 Roche Diagnostics Expanding Manufacturing Capacity, Testing Portfolio in 2021 Premium Load More Breaking News Immunai Closes $215M Series B Round DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants GenomSys Gains CE Mark for New Genomic Analysis Software Thermo Fisher Scientific Q3 Revenues up 9 Percent BTIG Initiates Coverage of LumiraDx With Buy Rating The Scan Panel Recommends Pfizer-BioNTech Vaccine for Kids CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old. Sharing How to Make It Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times. Bring it Back In Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray. Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.